Current warnings week 7 - 2022
In February 2022, we tested a number of substances of particular health concern. In a sample submitted as MDMA, the new psychoactive substance Pentylon was detected. One sample submitted as MMC contained instead 3-MeO-PCE. Two samples submitted as mephedrone (4-MMC) instead contained once Clophedrone (3-CMC) and once Clephedrone (4-CMC). In a hashish sample, the synthetic cannabinoid ADB-BUTINACA detected, one cannabis sample contained a unknown substance.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 7-2022
Current warnings week 5 - 2022
In January 2022, we tested a number of substances of particular health concern. Instead of MDMA, one ecstasy tablet contained Amphetamine and Caffeine. A sample passed off as LSD contained instead of LSD a unknown substance. A sample submitted as heroin showed two unknown substances .
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 5-2022
Current warnings week 3 - 2022
In January 2022, we tested a number of substances of particular health concern. A powder dispensed as etizolam contained the long-acting benzodiazepine Flubromazepam. In a sample submitted as methamphetamine, the phenethylamine 2C-B proven.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 3-2022
Current warnings week 51-2021
In December 2021, we tested a number of substances of particular health concern. One sample submitted as speed did not contain the expected amphetamine but instead contained Methamphetamine. In an ecstasy tablet, instead of MDMA, the ingredients Domperidone, meta-chlorophenylpiperazine (mCPP) and Caffeine detected. On a cannabis sample a unknown substance proven.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 51-2021
Current warnings week 49-2021
In November 2021, we tested a number of substances of particular health concern. One as 2C-B tablet showed besides 2C-B two unknown substances on. In several Ecstasy-pills, instead of MDMA, a unknown substance .
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 49-2021
Current warnings week 47-2021
In November 2021, we tested a number of substances of particular health concern. One tablet submitted for analysis as ecstasy contained Amphetamine and Caffeine identified. In addition to cocaine, some samples submitted as cocaine also contained Levamisole. A crystalline sample delivered as A-PHP (alpha-pyrrolidinohexiophenone) exhibited a unknown substance .
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 47-2021
Current warnings KW 45-2021
In October and early November 2021, we tested a number of substances of particular health concern. In addition to cannabis, three samples submitted as cannabis also contained the synthetic cannabinoid ADB-BUTINACA. In a sample submitted as mephedrone Clophedrone (3-CMC)in another sample submitted as mephedrone 3-Methylmethcathinone (3-MMC) was detected. One tablet dispensed as 2C-B showed 2-Br-4,5-DMPEA (6-Br-DMPEA) .
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 45-2021
Current warnings week 41-2021
In October 2021, we tested a number of substances of particular health concern. In two tablets sold as ecstasy, instead of the expected MDMA, both Amphetamine as well as Caffeine proven. The synthetic cannabinoid ADB-BUTINACA was identified in two samples submitted for analysis as cannabis.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 41-2021
Current warnings October 2021 - Event
At the beginning of October 2021, we tested a number of substances of particular health concern during mobile drug checking at an event. Instead of the expected MDMA, a tablet handed out as ecstasy contained both Amphetamine as well as Caffeine. Furthermore, in a sample submitted as ketamine, the new psychoactive substance 2-Fluorodeschloroketamine identified.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 40-2021
Current warnings week 39-2021
In September 2021, we tested a number of substances of particular health concern. A sample purchased as ketamine also contained, in addition to ketamine Methamphetamine. Various tablets sold as ecstasy did not contain MDMA, but instead contained Amphetamine and caffeine. In addition, various new psychoactive substances were detected in some other samples. One sample purchased as mephedrone (4-MMC) instead contained Clephedrone (4-CMC)another mephedrone sample contained 3-MMC, clephedrone (4-CMC) and an unknown substance. On a cannabis sample, the two synthetic cannabinoids EDMB-PINACA and ADB-4en-PINACA detected. In addition to cocaine, a cocaine sample also contained Clephedrone (4-CMC), levamisole and phenacetin proven.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 39-2021